FirstEnergy Corp. vs ImmunityBio Inc. Common Stock — how do they compare? FirstEnergy Corp. trades at $44.9 (market cap $25.80B), while ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B). The key difference: FirstEnergy Corp. is far larger — about 2.5× ImmunityBio Inc. Common Stock's market cap, and FirstEnergy Corp. pays a 4.17% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FirstEnergy Corp. for 71 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FE | IBRX | |
|---|---|---|
Market Cap | $25.80B | $10.33B |
Volume | 5,328,616 | 11,745,198 |
Sector | Utilities | Health |
52-Week High | $51.91 | $11.55 |
52-Week Low | $43.04 | $1.98 |
Typical Hold Time | 71 Days | 0 Days |
Enterprise Value | $54.72B | $10.79B |
Dividend Yield | 4.17% | — |
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $44.85, up 1.33% with mixed technical signals showing bullish overall but bearish moving averages. The company reported Q1 2026 EPS beat but missed Q4 2025 and Q2 2026 expectations, with Q3 2026 results pending. Revenue grew to $15.09B in 2025 with stable profit margins around 6.86%. Recent developments include the $36B Energize365 investment plan and consistent dividend payments, supporting long-term growth prospects in the utility sector.
FE presents a moderate buy opportunity with analyst consensus target of $52.80 offering 17.7% upside. Strong institutional interest and dividend stability balance execution risks from heavy capital expenditures and debt levels. The stock's valuation appears reasonable with P/E of 23.84, though investors should monitor earnings consistency and regulatory developments in the electric utility space.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →